The weekly federal-spending brief. One email a Sunday. Free. No tracking.
The BuildoutBeta

$42,670,608

Department of Health and Human Services·National Institutes of Health

to THE EMMES COMPANY, LLC

healthexpiredONGOING · MOD OF 2021 CONTRACT
WORK BEGAN2021-06-01·LATEST ACTION2026-05-11·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75N91021C00009_7529_-NONE-_-NONE-
Award description

CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high
In plain English

A 2026 increment to the 2021 Emmes clinical trials contract supporting NIH research data management and trial operations.

Sub-sectors
clinical-trialsnih-research-supportdata-management
Why this matters

Clinical trial infrastructure supports drug development and regulatory approvals; robust data management ensures trial integrity and innovation acceleration.

Supply-chain signal

Steady CRO demand signals robust NIH-sponsored research pipeline across pharmaceutical and biotech sectors.

U.S.–China competition angle

U.S. clinical trial infrastructure supports American biotech leadership as China rapidly expands rival trial capacity and pharma innovation.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-12. Cost: $0.014223.

Period of performance
Start
2021-06-01
End
2026-05-31
Status
expired31 days ago
Sources

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.